[Edaily JAEMIN SONG Choi Oh-hyun Reporter] “We have established the following as our core principles for capital allocation: striking a balance between future investments to secure structural growth opportunities in the AI era, maintaining a stable financial structure, and shareholder returns to enhance shareholder value. We are fully aware of the market’s high interest in shareholder returns and are reviewing various additional shareholder return measures. We will prepare to share these plans with the market and investors within the year as soon as they are finalized. Going forward, we will continue to execute growth investments in a timely manner while also pursuing a balanced capital allocation policy aimed at enhancing shareholder value.”
…SK hynix Q2 2026 Conference Call
A view of SK hynix’s headquarters in Icheon, Gyeonggi Province. (Photo: Yonhap News)
Business leaders from South Korea and Brazil have agreed to expand cooperation across a wide range of strategic industries, from critical mineral supply chains to artificial intelligence (AI), biotech…
Ingenia Therapeutics (Ingenia), an innovative antibody drug developer set to list on KOSDAQ, has brought a treatment for chronic kidney disease (CKD) to the negotiating table with a global big pharma …
AHNLAB,INC.(053800)announced preliminary financial results on the 29th, reporting consolidated revenue of 130.4 billion won and operating profit of 7.3 billion won for the first half of this year.
…
